Zobrazeno 1 - 10
of 350
pro vyhledávání: '"Jean-Pascal Machiels"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Gestational trophoblastic neoplasia (GTN) is extremely rare, but has a very good prognosis, with a cure rate close to 100%, for low-risk diseases. This article describes the case of a healthy 28-year-old nulliparous patient with GTN resistant to mult
Externí odkaz:
https://doaj.org/article/2b198b70c574461f9089122beb2c7b1a
Autor:
Hanna M. Peacock, Cindy De Gendt, Geert Silversmit, Sandra Nuyts, Jan Casselman, Jean-Pascal Machiels, Francesco Giusti, Bart van Gool, Vincent Vander Poorten, Liesbet Van Eycken
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveDuring the first wave of the COVID-19 pandemic in 2020, non-essential health services were suspended in Belgium, and the public was ordered to socially isolate. Underdiagnosis of cancer during this period was reported worldwide. Certain risk
Externí odkaz:
https://doaj.org/article/d29613cc933647f8a70a64f366d04ffe
Autor:
Fanny Collette, Marc Hamoir, Pascal Van Eeckhout, Philippe D’Abadie, Thierry Duprez, Sandra Schmitz, Jean‐Pascal Machiels
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 3471-3477 (2020)
Abstract Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti‐androgen thera
Externí odkaz:
https://doaj.org/article/4882b7e7ba0f4296a51ba7d8d5eaf7c0
Autor:
Cédric Van Marcke, Raphaël Helaers, Anne De Leener, Ahmad Merhi, Céline A. Schoonjans, Jérôme Ambroise, Christine Galant, Paul Delrée, Françoise Rothé, Isabelle Bar, Elsa Khoury, Pascal Brouillard, Jean-Luc Canon, Peter Vuylsteke, Jean-Pascal Machiels, Martine Berlière, Nisha Limaye, Miikka Vikkula, François P. Duhoux
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-13 (2020)
Abstract Background Multigene panels are routinely used to assess for predisposing germline mutations in families at high breast cancer risk. The number of variants of unknown significance thereby identified increases with the number of sequenced gen
Externí odkaz:
https://doaj.org/article/44b3c35783f64909bdc3137b3da359fb
Autor:
Konrad Klinghammer, Luigi Lorini, Daan Nevens, Christian Simon, Jean-Pascal Machiels, Paolo Bossi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Multiple factors differentially influence treatment decisions in the first line treatment of recurrent/metastatic HNSCC. The EORTC Young investigator group launched a survey among treating physicians to explore the main influencing factors for treatm
Externí odkaz:
https://doaj.org/article/175710d8ff0e4d04a759a17b2d2b17f4
Autor:
Bhumsuk Keam, Kevin Harrington, Ezra Cohen, Jean-Pascal Machiels, Feng Jin, Alison Forgie, Shanhong Guan, Jaume Pons, Beatriz Cirauqui, Sjoukje Oosting, Tim Welliver, Philip Fanning, Katherine Ruffner, Sophia Randolph
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d858740a794e4250bfede0ea7bc6d9c4
Autor:
Sara I. Pai, Sandrine Faivre, Lisa Licitra, Jean-Pascal Machiels, Jan B. Vermorken, Paolo Bruzzi, Viktor Gruenwald, Raul E. Giglio, C. René Leemans, Tanguy Y. Seiwert, Denis Soulieres
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-4 (2019)
Abstract Two phase III clinical trials (CheckMate 141 and KEYNOTE 040) have independently demonstrated that overall survival (OS) in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients, who have failed platinum-base
Externí odkaz:
https://doaj.org/article/f0b003406a0943e7b05d2212424c9c8d
Autor:
Jean-Pascal Machiels, Ramon Salazar, Sylvie Rottey, Ignacio Duran, Luc Dirix, Karen Geboes, Christine Wilkinson-Blanc, Gillian Pover, Simon Alvis, Brian Champion, Kerry Fisher, Hilary McElwaine-Johnn, John Beadle, Emiliano Calvo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-15 (2019)
Abstract Background Enadenotucirev is a chimeric adenovirus with demonstrated preclinical tumor-selective cytotoxicity and a short half-life. Further clinical mechanism of action data showed that enadenotucirev can gain access to and replicate within
Externí odkaz:
https://doaj.org/article/26c0983875fa4d0da5e0fc2f0a11a2aa
Autor:
Ben Tran, Nabil Adra, Jean-Pascal Machiels, Sylvie Rottey, Tanya Dorff, Lisa Horvath, Matthew Rettig, Martijn Lolkema, Karen Autio, Richard Greil, Shirley Poon, Daniel Tan, Gabor Jurida, Hosein Kouros-Mehr
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/adaacf7cb04b45f685d2be6482fb3256
Autor:
Makoto Tahara, Kevin Harrington, Ezra Cohen, Barbara Burtness, Quynh-Thu Le, Lisa Licitra, Jean-Pascal Machiels, Lilian Siu, Danny Rischin, Jan Vermorken, Natalyn Hawk, Joy Ge, Behzad Bidadi, Ramona Swaby
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d443e2b163b84871800faa18022a15ef